Viewing Study NCT06358651

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-01-16 @ 6:34 AM
Study NCT ID: NCT06358651
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-26
First Post: 2024-04-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
Sponsor: VistaGen Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Social Anxiety Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fasedienol View
None PH94B View
None Social Anxiety Disorder View
None SAD View
None pherine View
None pherine nasal spray View
None acute treatment View
None anxiety treatment View
None acute anxiety treatment View
None anxiotlytic View
None mental health View
None anxiety View
None anxiety nasal spray View
None PSC View
None public speaking challenge View
None social phobia View